Patients With IBD Receiving Methotrexate Are at Higher Risk of Liver Injury Compared With Patients With Non-IBD Diseases: A Meta-Analysis and Systematic Review

Background: Methotrexate is well-known in treating inflammatory bowel disease (IBD), rheumatoid arthritis (RA), psoriasis (Ps), and psoriatic arthritis (PsA). Several reports have indicated a higher incidence of methotrexate (MTX)-related liver adverse events in patients with IBD. We aim to investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yang, Li, Yimin, Liu, Yun, Zhang, Yifan, Ke, Ziliang, Zhang, Yu, Liu, Yulan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645797/
https://www.ncbi.nlm.nih.gov/pubmed/34881269
http://dx.doi.org/10.3389/fmed.2021.774824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645797/
https://www.ncbi.nlm.nih.gov/pubmed/34881269
http://dx.doi.org/10.3389/fmed.2021.774824

Ejemplares similares